EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split‐face pilot study

Sun Young Choi iD, Young Gue Koh iD, Yoon Jin Roh iD, Kui Young Park iD

Journal of Cosmetic Dermatology · 2024-08 · 23 (8) · 2657-2662

DOI: 10.1111/jocd.16329 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Cosmetic Dermatology, online erschienen am 15.04.2024. Verfasst von Sun Young Choi und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, South Korea. Hauptthemen laut MEDLINE: Erythema. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Trade, Industry and Energy, NAOS Inc.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Enoxolone, derived from licorice, possesses potent anti‐inflammatory, and antioxidant properties. However, its effectiveness in alleviating post‐laser reactions has not been extensively studied.

Aims

This randomized split‐face pilot study aimed to evaluate the effects of enoxolone on skin following laser treatment. Patients/Methods Ten healthy subjects underwent non‐ablative 1550 nm Er:Glass fractional laser treatment and then randomly applied a moisturizer without enoxolone on one side of the face and a dermo‐cosmetic formular containing 2% enoxolone mixed with the same moisturizer on the other side. The erythema index (EI), clinician's erythema assessment (CEA), and pain scores were recorded at 30 min, 60 min, and 24 h posttreatment.

Results

The group treated with enoxolone showed significantly lower EI and CEA compared to the control group at 24 h posttreatment. Additionally, pain scores were notably reduced in the enoxolone‐treated group 30 min after treatment.

Conclusions

This study suggests that dermo‐cosmetic formular containing 2% enoxolone is effective in reducing erythema and pain following laser treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ErythemaHumansPilot ProjectsFemaleAdultPain MeasurementTreatment OutcomeMaleLasers, Solid-StateAnti-Inflammatory AgentsMiddle AgedFaceSkinHealthy VolunteersSkin Cream

Stichwörter der Autor:innen

enoxoloneerythemalaser therapy

Substanzen

Anti-Inflammatory Agents

Autor:innen und Institutionen

  • Department of Dermatology, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine, Gwangmyeong, South Korea.
  • Department of Dermatology, Chung-Ang University Hospital, Chung-Ang University College of Medicine, Seoul, South Korea.

ORCID-Profile: Sun Young Choi, Young Gue Koh, Yoon Jin Roh, Kui Young Park

Förderung

  • Ministry of Trade, Industry and Energy
  • NAOS Inc

Zitieren

APA

Choi, S. Y., Koh, Y. G., Roh, Y. J., & Park, K. Y. (2024). The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split‐face pilot study. Journal of Cosmetic Dermatology, 23(8), 2657-2662. https://doi.org/10.1111/jocd.16329

Vancouver

Choi SY, Koh YG, Roh YJ, Park KY. The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split‐face pilot study. Journal of Cosmetic Dermatology. 2024;23(8):2657-2662. doi:10.1111/jocd.16329

BibTeX
@article{Choi2024,
  author = {Choi, Sun Young and Koh, Young Gue and Roh, Yoon Jin and Park, Kui Young},
  title = {The efficacy of enoxolone in reducing erythema and pain after laser treatment: A randomized split‐face pilot study},
  journal = {Journal of Cosmetic Dermatology},
  year = {2024},
  volume = {23},
  number = {8},
  pages = {2657--2662},
  doi = {10.1111/jocd.16329}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche